SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > AstraZeneca

Pharma Consortium to investigate new drug development technique

04-Apr-2016 - The new consortium will evaluate cryo-electron microscopy’s potential for drug development.

Dispatches from PCT

Patient-centric trials to give CROs competitive edge, say sponsors

19-Nov-2015 - A more patient-focused approach will expedite clinical trials and responsive CROs will have the competitive advantage, say AstraZeneca, EMD and Bayer.

Roche: Small molecule exit will lead to outsourcing opportunities

16-Nov-2015 - Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.

Clinigen and Cumberland collaborate in mutual market access deal

17-Sep-2015 - UK-based Clinigen and US-based Cumberland Pharmaceuticals have struck a deal to market each others products outside their respective countries.

$47m innovation facility built in Nottingham, UK

21-Aug-2015 - The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture...

Charles River plans cautious approach to re-opening of Shrewsbury preclinical site

14-Aug-2015 - After months of speculation , Charles River Laboratories has decided to move forward with the re-opening of its early-stage research site in Shrewsbury, Massachusetts sometime in the first quarter of 2016.

Environmental group welcomes DSM-Sinochem and GSK efforts to halt spread of antibiotic resistance

13-Jul-2015 - Antibiotic API makers have an obligation to ensure their activities do not spread resistance says a group that welcomed DSM-Sinochem’s commitment to environmentally-friendly production.

Roundup of new CRO tech, research collaborations and more

19-Jun-2015 - The 51st annual DIA conference in Washington, DC has been abuzz all week with new offerings from the top CROs (contract research organizations), in addition to new collaborations between top...

CROs look to buttress research models businesses with CRISPR/Cas tech

25-May-2015 - As the largest pharma and tech suppliers – from Novartis  to GE Healthcare  to Thermo Fisher  – begin exploring the world of CRISPR/Cas gene editing technology, contract research organizations are also looking into the new tech...

PEOPLE ON THE MOVE

Outsourcing jobs: people on the move in pharma

13-May-2015 -

Dispatches from PCT US

Experts discuss the impact of M&A on CRO, sponsor partnerships

24-Apr-2015 - As M&A continues to ramp up for the pharma and biotech industry, communication and agility are two of the major keys for CROs to adapt to an acquisition, experts said...

AstraZeneca inks two research partnerships with PatientsLikeMe, Lead Discovery Center

14-Apr-2015 - With an eye on early-phase research, AstraZeneca has signed two deals – a five-year agreement to gain access to PatientsLikeMe’s network, and a three-year alliance with the Lead Discovery Center.

Quintiles, Parexel, PPD lead all CROs in US trial totals, review finds

14-Apr-2015 - CROs (contract research organizations) continue to collaborate with sponsors on more clinical trials in the US, though the largest companies, such as Quintiles, Parexel and PPD, are working on a...

Update

TransCelerate launches two new initiatives to accelerate clinical trials

10-Apr-2015 - Industry group TransCelerate BioPharma has established two new global initiatives around placebo and standard of care data sharing, and electronic labels for clinical trials – both of which aim to...

News in brief

CFDA accepts WuXi-MedImmune’s IND for new mAb

31-Mar-2015 - The China Food and Drug Administration (CFDA) has accepted for review an Investigational New Drug (IND) application for WuXi and MedImmune's novel anti-IL6 monoclonal antibody (mAb) for rheumatoid arthritis. ...

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...

AstraZeneca R&D arm signs five-year deal with NIST to advance discovery, manufacturing

23-Feb-2015 - MedImmune, the biologics R&D arm of AstraZeneca, and the US National Institute of Standards and Technology (NIST) have signed a five-year agreement to support research that will help advance drug...

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012. 

After AZ R&D exit, CMOs anxious to keep pharma in the country

11-Dec-2014 - Pharma companies have called on the Swedish government to prevent manufacturing going the way of R&D and leaving the country, after AstraZeneca closed its research in Lund in 2012.

Collaboration can fix ‘broken’ clinical trials model TransCelerate CEO tells CROs

18-Nov-2014 - Collaboration does not mean drugmakers have started playing nice, it’s just that the pain of shared problems has become unbearable according to TransCelerate Biopharma CEO, Dalvir Gill.

Dispatches from the Financial Times Global Pharmaceutical and Biotechnology Conference

Pipelines not tax cutting should prompt smaller pharma mergers says AstraZeneca exec

18-Nov-2014 - 2014 has seen record pharma M&A activity but top management of some of the key dealmakers – including Novartis, AstraZeneca and Shire – say size doesn’t always matter.

Sanofi wearable injectable supply deal could net Unilife over $1bn per year

12-Nov-2014 - Unilife says its 15 year-wearable injector supply deal with Sanofi is “unprecendented” and could result in over $1bn of sales annually for the delivery device maker. 

AstraZeneca brings IT services in-house with new Indian facility

25-Sep-2014 - The opening of a global IT centre in India will bring services back in-house, but AstraZeneca says it is not changing its outsourcing strategy for R&D and manufacturing.

Key Industry Events